| COVID-19 and drug-induced liver injury: a problem of plenty or a petty point? J Boeckmans, RM Rodrigues, T Demuyser, D Pierard, T Vanhaecke, ... Archives of toxicology 94, 1367-1369, 2020 | 155 | 2020 |
| Anti-NASH drug development hitches a lift on PPAR agonism J Boeckmans, A Natale, M Rombaut, K Buyl, V Rogiers, J De Kock, ... Cells 9 (1), 37, 2019 | 99 | 2019 |
| Human-based systems: Mechanistic NASH modelling just around the corner? J Boeckmans, A Natale, K Buyl, V Rogiers, J De Kock, T Vanhaecke, ... Pharmacological research 134, 257-267, 2018 | 51 | 2018 |
| An exploratory approach for an oriented development of an untargeted hydrophilic interaction liquid chromatography-mass spectrometry platform for polar metabolites in … E Iturrospe, KM Da Silva, BT Andújar, M Cuykx, J Boeckmans, ... Journal of Chromatography a 1637, 461807, 2021 | 36 | 2021 |
| Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonists J Boeckmans, A Natale, M Rombaut, K Buyl, B Cami, V De Boe, ... Cell Biology and Toxicology 37, 293-311, 2021 | 29 | 2021 |
| Elafibranor restricts lipogenic and inflammatory responses in a human skin stem cell-derived model of NASH J Boeckmans, K Buyl, A Natale, V Vandenbempt, S Branson, V De Boe, ... Pharmacological Research 144, 377-389, 2019 | 28 | 2019 |
| Infections at the nexus of metabolic-associated fatty liver disease J Boeckmans, M Rombaut, T Demuyser, B Declerck, D Piérard, V Rogiers, ... Archives of Toxicology 95, 2235-2253, 2021 | 26 | 2021 |
| Direct reprogramming of somatic cells into induced hepatocytes: Cracking the Enigma code M Rombaut, J Boeckmans, RM Rodrigues, LA van Grunsven, ... Journal of Hepatology 75 (3), 690-705, 2021 | 21 | 2021 |
| Technological advancements for the development of stem cell-based models for hepatotoxicity testing A Natale, K Vanmol, A Arslan, S Van Vlierberghe, P Dubruel, J Van Erps, ... Archives of toxicology 93, 1789-1805, 2019 | 18 | 2019 |
| Optimization of the Cohesion Index in the SeDeM Diagram Expert System and application of SeDeM Diagram: An improved methodology to determine the Cohesion Index I Nofrerias, A Nardi, M Suñé-Pou, J Boeckmans, JM Suñé-Negre, ... PLoS One 13 (9), e0203846, 2018 | 15 | 2018 |
| Metabolic signature of ethanol-induced hepatotoxicity in HepaRG cells by liquid chromatography–mass spectrometry-based untargeted metabolomics E Iturrospe, KM da Silva, R Robeyns, M van de Lavoir, J Boeckmans, ... Journal of proteome research 21 (4), 1153-1166, 2022 | 13 | 2022 |
| Inflammation alters the secretome and immunomodulatory properties of human skin-derived precursor cells J De Kock, RM Rodrigues, S Branson, L Verhoye, H Colemonts-Vroninks, ... Cells 9 (4), 914, 2020 | 11 | 2020 |
| Hepatic cells derived from human skin progenitors show a typical phospholipidotic response upon exposure to amiodarone A Natale, J Boeckmans, T Desmae, V De Boe, J De Kock, T Vanhaecke, ... Toxicology Letters 284, 184-194, 2018 | 10 | 2018 |
| PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic review J Boeckmans, A Gatzios, JM Schattenberg, GH Koek, RM Rodrigues, ... Liver International 43 (5), 975-988, 2023 | 9 | 2023 |
| Transcriptomics reveals discordant lipid metabolism effects between in vitro models exposed to elafibranor and liver samples of NAFLD patients after bariatric surgery J Boeckmans, A Gatzios, A Heymans, M Rombaut, V Rogiers, J De Kock, ... Cells 11 (5), 893, 2022 | 8 | 2022 |
| Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: novel therapeutic targets L Yang, Y Hao, J Boeckmans, RM Rodrigues, Y He Pharmacology & Therapeutics 243, 108353, 2023 | 7 | 2023 |
| Follow-up testing of borderline SARS-CoV-2 patients by rRT-PCR allows early diagnosis of COVID-19 J Boeckmans, R Cartuyvels, P Hilkens, L Bruckers, K Magerman, ... Diagnostic Microbiology and Infectious Disease 100 (2), 115350, 2021 | 7 | 2021 |
| Flow cytometric quantification of neutral lipids in a human skin stem cell-derived model of NASH J Boeckmans, A Natale, M Rombaut, K Buyl, T Vanhaecke, V Rogiers, ... MethodsX 7, 101068, 2020 | 7 | 2020 |
| From NAFLD to MAFLD: aligning translational in vitro research to clinical insights A Gatzios, M Rombaut, K Buyl, J De Kock, RM Rodrigues, V Rogiers, ... Biomedicines 10 (1), 161, 2022 | 5 | 2022 |
| Anti-NASH drug develop-ment hitches a lift on PPAR agonism. Cells. 2019; 9 (1): 37 J Boeckmans, A Natale, M Rombaut | 5 | |
